Frontiers in Genetics | Cancer Genetics and Oncogenomics

Original Research

Published on 03 Jan 2025

The value of a metabolic and immune-related gene signature and adjuvant therapeutic response in pancreatic cancer

in Cancer Genetics and Oncogenomics

Danlei Ni
Jiayi Wu
Jingjing Pan
Yajing Liang
Zihui Xu
Zhiying Yan
Kequn Xu
Feifei Wei

Frontiers in Genetics

doi 10.3389/fgene.2024.1475378

838 views

Review

Published on 23 Dec 2024

Viral infection, APOBEC3 dysregulation, and cancer

in Cancer Genetics and Oncogenomics

Jake Lehle
Mohadeseh Soleimanpour
Samira Mokhtari
Diako Ebrahimi

Frontiers in Genetics

doi 10.3389/fgene.2024.1489324

1,502 views

Review

Published on 19 Dec 2024

Dysregulation of ubiquitination modification in renal cell carcinoma

in Cancer Genetics and Oncogenomics

Hongjie You
Hui Zhang
Xiaofeng Jin
Zejun Yan

Frontiers in Genetics

doi 10.3389/fgene.2024.1453191

1,041 views

Original Research

Published on 19 Dec 2024

A comprehensive analysis of vasculogenic mimicry related genes to predict the survival rate of HCC and its influence on the tumor microenvironment

in Cancer Genetics and Oncogenomics

Jingyun Wang
Rong Gao
Jian Qi
Yingru Xing
Bo Hong
Hongzhi Wang
Jinfu Nie

Frontiers in Genetics

doi 10.3389/fgene.2024.1437715

1,170 views

Original Research

Published on 17 Dec 2024

Identification and validation the predictive biomarkers based on risk-adjusted control chart in gemcitabine with or without erlotinib for pancreatic cancer therapy

in Cancer Genetics and Oncogenomics

Aijun Zhao
Dongsheng Tu
Ye He
Liu Liu
Bin Wu
Yixing Ren

Frontiers in Genetics

doi 10.3389/fgene.2024.1497254

912 views

Original Research

Published on 09 Dec 2024

Integration of single-cell and bulk analysis reveals TBXAS1 as a key platelet-related gene causing poor prognosis in osteosarcoma

in Cancer Genetics and Oncogenomics

Han Liu
Wacili Da
Jianhua Mu
Xuanhong He
Zhuangzhuang Li
Taojun Gong
Jingjing Wang
Li Min
Minxun Lu
Chongqi Tu

Frontiers in Genetics

doi 10.3389/fgene.2024.1519529

954 views

Original Research

Published on 06 Dec 2024

Real-world efficacy and safety of combined first-line treatment with PARP inhibitors and novel hormonal therapy in mCRPC patients with HRR gene mutations

in Cancer Genetics and Oncogenomics

Andong Guo
Chenrui Wu
Jishuang Cao
Kejia Zhu
Sentai Ding

Frontiers in Genetics

doi 10.3389/fgene.2024.1505163

826 views

Original Research

Published on 05 Dec 2024

Exploring the impact of deubiquitination on melanoma prognosis through single-cell RNA sequencing

in Cancer Genetics and Oncogenomics

Su Peng
Jiaheng Xie
Xiaohu He

Frontiers in Genetics

doi 10.3389/fgene.2024.1509049

881 views

Original Research

Published on 05 Dec 2024

BIRC5 as a prognostic and diagnostic biomarker in pan-cancer: an integrated analysis of expression, immune subtypes, and functional networks

in Cancer Genetics and Oncogenomics

Guoyu Li
Yanghao Wang
Weizhou Wang
Guodong Lv
Xiang Li
Jingying Wang
Xiuyu Liu
Daolang Yuan
Shoujun Deng
Dingyun You

Frontiers in Genetics

doi 10.3389/fgene.2024.1509342

1,295 views

Correction

Published on 04 Dec 2024

Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

in Cancer Genetics and Oncogenomics

Haiyang Zhao
Kexin Luo
Meihan Liu
Yuanze Cai
Siman Liu
Shijuan Li
Yongsheng Zhao
Hongpan Zhang

Frontiers in Genetics

doi 10.3389/fgene.2024.1531321

493 views

Review

Published on 29 Nov 2024

PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for

in Cancer Genetics and Oncogenomics

Sara Parola
Christoph Oing
Pasquale Rescigno
Salvatore Feliciano
Francesca Carlino
Luca Pompella
Antonella Lucia Marretta
Irene De Santo
Martina Viggiani
Margherita Muratore

Frontiers in Genetics

doi 10.3389/fgene.2024.1480417

959 views

Original Research

Published on 29 Nov 2024

Gradient boosting reveals spatially diverse cholesterol gene signatures in colon cancer

in Cancer Genetics and Oncogenomics

Xiuxiu Yang
Debolina Chatterjee
Justin L. Couetil
Ziyu Liu
Valerie D. Ardon
Chao Chen
Jie Zhang
Kun Huang
Travis S. Johnson

Frontiers in Genetics

doi 10.3389/fgene.2024.1410353

990 views

Original Research

Published on 27 Nov 2024

Exploring the therapeutic potency of cryptotanshinone in cervical cancer: a multi-omics and network pharmacology approach

in Cancer Genetics and Oncogenomics

Zenghong Lu
Gangfeng Zhu
Xiaofei Feng
Yi Xiang
Cixiang Chen
Huiting Yuan
Zhixing Chen

Frontiers in Genetics

doi 10.3389/fgene.2024.1435132

1,130 views

Original Research

Published on 22 Nov 2024

Holliday junction recognition protein (HJURP) could reflect the clinical outcomes of lung adenocarcinoma patients, and impact the choice of precision therapy

in Cancer Genetics and Oncogenomics

Xixi Gao
Yingqing Zhang
Ming Zhang
Yuejiao Sun

Frontiers in Genetics

doi 10.3389/fgene.2024.1475511

1,455 views

Original Research

Published on 22 Nov 2024

Bioinformatics insights into the role of GFPT1 in breast invasive carcinoma: implications for tumor prognosis, immune modulation, and therapeutic applications

in Cancer Genetics and Oncogenomics

Jianghui Liang
Xiaolian Deng
Yingyi Zhang
Tianchi Fei
Muzi Ouyang
Chengjie Yu
Yang Xiang
Dongwei Jia
Fangfang Duan

Frontiers in Genetics

doi 10.3389/fgene.2024.1482929

1,252 views

Original Research

Published on 14 Nov 2024

A scoring model based on bacterial lipopolysaccharide-related genes to predict prognosis in NSCLC

in Cancer Genetics and Oncogenomics

Nandi Bao
Xinxin Zhang
Chenyu Lin
Feng Qiu
Guoxin Mo

Frontiers in Genetics

doi 10.3389/fgene.2024.1408000

1,493 views